239 related articles for article (PubMed ID: 35390708)
1. Disruption of dual homeostasis by a metal-organic framework nanoreactor for ferroptosis-based immunotherapy of tumor.
Zhang K; Ma Z; Li S; Wu Y; Zhang J; Zhang W; Zhao Y; Han H
Biomaterials; 2022 May; 284():121502. PubMed ID: 35390708
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Targeted Cascade Nanoreactor Based on Metal-Organic Frameworks for Synergistic Ferroptosis-Starvation Anticancer Therapy.
Wan X; Song L; Pan W; Zhong H; Li N; Tang B
ACS Nano; 2020 Sep; 14(9):11017-11028. PubMed ID: 32786253
[TBL] [Abstract][Full Text] [Related]
3. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
[TBL] [Abstract][Full Text] [Related]
4. Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy.
Yang J; Ma S; Xu R; Wei Y; Zhang J; Zuo T; Wang Z; Deng H; Yang N; Shen Q
J Control Release; 2021 Jun; 334():21-33. PubMed ID: 33872626
[TBL] [Abstract][Full Text] [Related]
5. Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin.
Cheng J; Zhu Y; Xing X; Xiao J; Chen H; Zhang H; Wang D; Zhang Y; Zhang G; Wu Z; Liu Y
Theranostics; 2021; 11(11):5418-5429. PubMed ID: 33859755
[No Abstract] [Full Text] [Related]
6. Proton pump inhibitor-enhanced nanocatalytic ferroptosis induction for stimuli-responsive dual-modal molecular imaging guided cancer radiosensitization.
Zheng S; Hu H; Hou M; Zhu K; Wu Z; Qi L; Xia H; Liu G; Ren Y; Xu Y; Yan C; Zhao B
Acta Biomater; 2023 May; 162():72-84. PubMed ID: 36931419
[TBL] [Abstract][Full Text] [Related]
7. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
8. Dual-Responsive multifunctional "core-shell" magnetic nanoparticles promoting Fenton reaction for tumor ferroptosis therapy.
Chi H; Zhu G; Yin Y; Diao H; Liu Z; Sun S; Guo Z; Xu W; Xu J; Cui C; Xing XJ; Ma K
Int J Pharm; 2022 Jun; 622():121898. PubMed ID: 35688287
[TBL] [Abstract][Full Text] [Related]
9. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma.
Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X
J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186
[TBL] [Abstract][Full Text] [Related]
10. Nanoreactor based on single-atom nanoenzymes promotes ferroptosis for cancer immunotherapy.
Liu Y; Qi P; Chen G; Lang Z; Wang J; Wang X
Biomater Adv; 2024 Feb; 157():213758. PubMed ID: 38199000
[TBL] [Abstract][Full Text] [Related]
11. Chemodynamic and Photothermal Combination Therapy Based on Dual-Modified Metal-Organic Framework for Inducing Tumor Ferroptosis/Pyroptosis.
Deng H; Zhang J; Yang Y; Yang J; Wei Y; Ma S; Shen Q
ACS Appl Mater Interfaces; 2022 Jun; 14(21):24089-24101. PubMed ID: 35588091
[TBL] [Abstract][Full Text] [Related]
12. A gold nanoparticle engineered metal-organic framework nanoreactor for combined ferroptosis and mild photothermal therapy.
Wei R; Li Y; Gao P; Zhang X; Li X; Wang K; Pan W; Li N; Tang B
Chem Commun (Camb); 2023 May; 59(43):6509-6512. PubMed ID: 37133902
[TBL] [Abstract][Full Text] [Related]
13. Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator.
He YJ; Liu XY; Xing L; Wan X; Chang X; Jiang HL
Biomaterials; 2020 May; 241():119911. PubMed ID: 32143060
[TBL] [Abstract][Full Text] [Related]
14. FePt@MnO-Based Nanotheranostic Platform with Acidity-Triggered Dual-Ions Release for Enhanced MR Imaging-Guided Ferroptosis Chemodynamic Therapy.
Yang B; Liu Q; Yao X; Zhang D; Dai Z; Cui P; Zhang G; Zheng X; Yu D
ACS Appl Mater Interfaces; 2019 Oct; 11(42):38395-38404. PubMed ID: 31554396
[TBL] [Abstract][Full Text] [Related]
15. Three-Step Depletion Strategy of Glutathione: Tunable Metal-Organic-Framework-Engineered Nanozymes for Driving Oxidative/Nitrative Stress to Maximize Ferroptosis Therapy.
Li W; Liu S; Ding H; Zhao R; Zang P; Li S; Fang L; Li R; Zhang M; Yang P
Nano Lett; 2024 Feb; 24(6):2071-2080. PubMed ID: 38305186
[TBL] [Abstract][Full Text] [Related]
16. Oxygen Self-Generating Nanoreactor Mediated Ferroptosis Activation and Immunotherapy in Triple-Negative Breast Cancer.
Li K; Xu K; He Y; Yang Y; Tan M; Mao Y; Zou Y; Feng Q; Luo Z; Cai K
ACS Nano; 2023 Mar; 17(5):4667-4687. PubMed ID: 36861638
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
[TBL] [Abstract][Full Text] [Related]
18. Fe-MnO
Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X
Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713
[TBL] [Abstract][Full Text] [Related]
19. Renal Clearable Ultrasmall Single-Crystal Fe Nanoparticles for Highly Selective and Effective Ferroptosis Therapy and Immunotherapy.
Liang H; Wu X; Zhao G; Feng K; Ni K; Sun X
J Am Chem Soc; 2021 Sep; 143(38):15812-15823. PubMed ID: 34473493
[TBL] [Abstract][Full Text] [Related]
20. A Dihydroartemisinin-Loaded Nanoreactor Motivates Anti-Cancer Immunotherapy by Synergy-Induced Ferroptosis to Activate Cgas/STING for Reprogramming of Macrophage.
Li LG; Yang XX; Xu HZ; Yu TT; Li QR; Hu J; Peng XC; Han N; Xu X; Chen NN; Chen X; Tang JM; Li TF
Adv Healthc Mater; 2023 Nov; 12(28):e2301561. PubMed ID: 37567571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
